Ausgabe 6/2019
Inhalt (6 Artikel)
Autoantibodies against P29ING4 are associated with complex regional pain syndrome
N. T. Baerlecken, R. Gaulke, N. Pursche, T. Witte, M Karst, M. Bernateck
Retained or altered expression of major histocompatibility complex class I in patient-derived xenograft models in breast cancer
In Hye Song, Young-Ae Kim, Hyeonjin Lee, Hye Seon Park, In Ah Park, Chan Kyu Sim, Myeong Sup Lee, Gyungyub Gong, Hee Jin Lee
A high-risk laboratory profile of antiphospholipid antibodies and thrombosis is associated with a large number of extra-criteria manifestations in obstetric antiphospholipid syndrome
Sebastián Udry, José Omar Latino, Cristina Belizna, Silvia Perés Wingeyer, Diego Santiago Fernández Romero, Gabriela de Larrañaga
CD226 attenuates Treg suppressive capacity via CTLA-4 and TIGIT during EAE
Ning Wang, Shuang Liang, Jingyi Jin, Liang Fang, Qianli Ma, Xian Wang, Yun Song, Lihua Chen
Promotion on NLRC5 upregulating MHC-I expression by IFN-γ in MHC-I–deficient breast cancer cells
Ming-Zhen Zhao, Yu Sun, Xiao-Feng Jiang, Li Liu, Li Liu, Li-Xin Sun
Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancers
Bahareh Kashani, Zahra Zandi, Mohammad Reza Karimzadeh, Davood Bashash, Ali Nasrollahzadeh, Seyed H. Ghaffari